NDMC101 is a small molecule research compound that functions as a dual inhibitor of dipeptidyl peptidase-IV (DPP-IV) in T cells and the transcription factors NFATc1 and NF-kappaB, thereby demonstrating immunomodulatory properties. Its applications include in vitro studies of T-cell activation and inflammation, as well as in vivo research on autoimmune and inflammatory disease models.